LifeNews.com A federal judge scolded the Food and Drug Administration over its decision to loosen safety restrictions on mailing the dangerous abortion pill mifepristone that has killed millions of babies and injured countless thousands of women.
But the judge refused to immediately block the practice, instead pausing the case and giving the agency time to complete a review of the drug.
U.S. District Judge David Joseph, a Trump appointee in Lafayette, Louisiana, denied Louisiana Attorney General Liz Murrill’s request for a preliminary injunction that would have halted the FDA’s 2023 mail-order rules while the lawsuit proceeds. The judge placed the case in abeyance pending the FDA’s promised “good faith, evidence-based and expeditious review.”
“At this juncture, it is the completion of FDA’s promised good faith, evidence-based, and expeditious review … not ‘government by lawsuit’ that this Court finds to be in the public interest,” Joseph wrote.
He added that, given the limited information on which the FDA previously acted to loosen restrictions, the equities and public interest favor allowing the agency to finish its safety review.
…
Read Full Article Here… | Life News
Home | Caravan to Midnight (zutalk.com)
Be First to Comment